Potassium in PDB 3sza: Crystal Structure of Human ALDH3A1 - Apo Form
Enzymatic activity of Crystal Structure of Human ALDH3A1 - Apo Form
All present enzymatic activity of Crystal Structure of Human ALDH3A1 - Apo Form:
1.2.1.5;
Protein crystallography data
The structure of Crystal Structure of Human ALDH3A1 - Apo Form, PDB code: 3sza
was solved by
M.Khanna,
T.D.Hurley,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
50.00 /
1.48
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
61.412,
86.080,
170.396,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
16.5 /
18.7
|
Potassium Binding Sites:
The binding sites of Potassium atom in the Crystal Structure of Human ALDH3A1 - Apo Form
(pdb code 3sza). This binding sites where shown within
5.0 Angstroms radius around Potassium atom.
In total 4 binding sites of Potassium where determined in the
Crystal Structure of Human ALDH3A1 - Apo Form, PDB code: 3sza:
Jump to Potassium binding site number:
1;
2;
3;
4;
Potassium binding site 1 out
of 4 in 3sza
Go back to
Potassium Binding Sites List in 3sza
Potassium binding site 1 out
of 4 in the Crystal Structure of Human ALDH3A1 - Apo Form
 Mono view
 Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 1 of Crystal Structure of Human ALDH3A1 - Apo Form within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:K602
b:12.3
occ:1.00
|
O
|
A:HOH460
|
2.7
|
10.8
|
1.0
|
O
|
A:ASP322
|
2.7
|
9.1
|
1.0
|
O
|
A:HOH872
|
2.8
|
16.7
|
1.0
|
O
|
A:HOH640
|
3.1
|
12.4
|
1.0
|
O
|
A:THR321
|
3.2
|
8.1
|
1.0
|
C
|
A:ASP322
|
3.5
|
8.5
|
1.0
|
CB
|
A:ASP322
|
4.2
|
9.0
|
1.0
|
CA
|
A:VAL323
|
4.2
|
7.8
|
1.0
|
CB
|
A:LYS301
|
4.2
|
8.8
|
1.0
|
N
|
A:VAL323
|
4.3
|
8.0
|
1.0
|
N
|
A:LYS301
|
4.3
|
8.7
|
1.0
|
OE1
|
A:GLN300
|
4.3
|
10.2
|
1.0
|
C
|
A:THR321
|
4.3
|
7.1
|
1.0
|
CA
|
A:ASP322
|
4.4
|
8.3
|
1.0
|
N
|
A:ASP324
|
4.8
|
8.9
|
1.0
|
N
|
A:ASP322
|
4.8
|
8.0
|
1.0
|
C
|
A:VAL323
|
4.9
|
8.6
|
1.0
|
CA
|
A:LYS301
|
4.9
|
8.4
|
1.0
|
|
Potassium binding site 2 out
of 4 in 3sza
Go back to
Potassium Binding Sites List in 3sza
Potassium binding site 2 out
of 4 in the Crystal Structure of Human ALDH3A1 - Apo Form
 Mono view
 Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 2 of Crystal Structure of Human ALDH3A1 - Apo Form within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:K603
b:39.0
occ:1.00
|
O
|
A:HOH1065
|
2.6
|
37.2
|
1.0
|
O
|
A:HOH564
|
2.7
|
36.9
|
1.0
|
O
|
A:LYS439
|
2.7
|
28.9
|
1.0
|
O
|
A:TYR442
|
2.8
|
21.7
|
1.0
|
C
|
A:TYR442
|
3.8
|
20.6
|
1.0
|
C
|
A:LYS439
|
3.8
|
29.0
|
1.0
|
O
|
A:HOH528
|
4.0
|
28.8
|
1.0
|
O
|
A:PRO444
|
4.0
|
23.0
|
1.0
|
O
|
A:VAL440
|
4.2
|
26.3
|
1.0
|
CB
|
A:TYR442
|
4.2
|
20.0
|
1.0
|
N
|
A:TYR442
|
4.2
|
21.2
|
1.0
|
CA
|
A:TYR442
|
4.3
|
20.6
|
1.0
|
C
|
A:VAL440
|
4.4
|
26.5
|
1.0
|
CA
|
A:VAL440
|
4.4
|
27.8
|
1.0
|
O
|
A:PRO443
|
4.5
|
20.4
|
1.0
|
N
|
A:VAL440
|
4.5
|
28.2
|
1.0
|
C
|
A:PRO443
|
4.6
|
20.8
|
1.0
|
CA
|
A:LYS439
|
4.8
|
29.9
|
1.0
|
O
|
A:HOH615
|
4.9
|
27.3
|
1.0
|
N
|
A:PRO444
|
4.9
|
21.9
|
1.0
|
CB
|
A:LYS439
|
4.9
|
30.3
|
1.0
|
N
|
A:PRO443
|
4.9
|
20.7
|
1.0
|
|
Potassium binding site 3 out
of 4 in 3sza
Go back to
Potassium Binding Sites List in 3sza
Potassium binding site 3 out
of 4 in the Crystal Structure of Human ALDH3A1 - Apo Form
 Mono view
 Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 3 of Crystal Structure of Human ALDH3A1 - Apo Form within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:K601
b:20.4
occ:1.00
|
O
|
B:GLU79
|
2.6
|
14.3
|
1.0
|
O
|
B:HOH559
|
2.7
|
28.5
|
1.0
|
O
|
B:ALA82
|
2.8
|
10.3
|
1.0
|
O
|
B:HOH524
|
2.9
|
20.4
|
1.0
|
O
|
B:TRP80
|
3.0
|
12.1
|
1.0
|
C
|
B:TRP80
|
3.5
|
11.8
|
1.0
|
C
|
B:ALA82
|
3.8
|
9.4
|
1.0
|
O
|
B:HOH824
|
3.8
|
18.7
|
1.0
|
C
|
B:GLU79
|
3.8
|
13.3
|
1.0
|
CA
|
B:TRP80
|
3.8
|
11.7
|
1.0
|
N
|
B:ALA82
|
3.9
|
9.6
|
1.0
|
O
|
B:HOH561
|
3.9
|
11.4
|
1.0
|
CB
|
B:ALA82
|
4.1
|
11.6
|
1.0
|
CA
|
B:ALA82
|
4.1
|
10.2
|
1.0
|
CB
|
B:GLU84
|
4.2
|
10.5
|
1.0
|
N
|
B:TRP80
|
4.3
|
12.5
|
1.0
|
N
|
B:ALA81
|
4.4
|
10.8
|
1.0
|
C
|
B:ALA81
|
4.5
|
10.8
|
1.0
|
OE1
|
B:GLU84
|
4.6
|
21.8
|
1.0
|
O
|
B:ASP83
|
4.7
|
12.5
|
1.0
|
C
|
B:ASP83
|
4.7
|
10.5
|
1.0
|
CA
|
B:GLU84
|
4.8
|
9.1
|
1.0
|
N
|
B:GLU84
|
4.8
|
9.3
|
1.0
|
CG
|
B:GLU84
|
4.8
|
11.9
|
1.0
|
N
|
B:ASP83
|
4.9
|
10.7
|
1.0
|
CA
|
B:ALA81
|
4.9
|
10.8
|
1.0
|
|
Potassium binding site 4 out
of 4 in 3sza
Go back to
Potassium Binding Sites List in 3sza
Potassium binding site 4 out
of 4 in the Crystal Structure of Human ALDH3A1 - Apo Form
 Mono view
 Stereo pair view
|
A full contact list of Potassium with other atoms in the K binding
site number 4 of Crystal Structure of Human ALDH3A1 - Apo Form within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:K603
b:23.9
occ:1.00
|
O
|
B:LYS439
|
2.6
|
15.8
|
1.0
|
O
|
B:TYR442
|
2.7
|
11.5
|
1.0
|
O
|
B:HOH808
|
2.8
|
23.6
|
1.0
|
O
|
B:HOH926
|
2.9
|
31.6
|
1.0
|
O
|
B:HOH766
|
2.9
|
24.8
|
1.0
|
C
|
B:LYS439
|
3.7
|
16.2
|
1.0
|
C
|
B:TYR442
|
3.7
|
10.6
|
1.0
|
O
|
B:PRO444
|
4.0
|
13.0
|
1.0
|
O
|
B:VAL440
|
4.1
|
15.8
|
1.0
|
N
|
B:TYR442
|
4.1
|
10.6
|
1.0
|
C
|
B:VAL440
|
4.2
|
14.6
|
1.0
|
CA
|
B:TYR442
|
4.2
|
9.9
|
1.0
|
CA
|
B:VAL440
|
4.2
|
16.4
|
1.0
|
CB
|
B:TYR442
|
4.2
|
9.9
|
1.0
|
N
|
B:VAL440
|
4.4
|
15.6
|
1.0
|
O
|
B:HOH746
|
4.4
|
21.7
|
1.0
|
O
|
B:HOH582
|
4.5
|
15.5
|
1.0
|
O
|
B:HOH798
|
4.5
|
20.2
|
1.0
|
O
|
B:PRO443
|
4.7
|
11.3
|
1.0
|
C
|
B:PRO443
|
4.7
|
10.8
|
1.0
|
CA
|
B:LYS439
|
4.8
|
16.9
|
1.0
|
N
|
B:ARG441
|
4.9
|
12.2
|
1.0
|
N
|
B:PRO443
|
4.9
|
10.1
|
1.0
|
CB
|
B:LYS439
|
4.9
|
17.9
|
1.0
|
O
|
B:HOH825
|
4.9
|
32.5
|
1.0
|
C
|
B:ARG441
|
5.0
|
10.9
|
1.0
|
|
Reference:
M.Khanna,
C.H.Chen,
A.Kimble-Hill,
B.Parajuli,
S.Perez-Miller,
S.Baskaran,
J.Kim,
K.Dria,
V.Vasiliou,
D.Mochly-Rosen,
T.D.Hurley.
Discovery of A Novel Class of Covalent Inhibitor For Aldehyde Dehydrogenases. J.Biol.Chem. V. 286 43486 2011.
ISSN: ISSN 0021-9258
PubMed: 22021038
DOI: 10.1074/JBC.M111.293597
Page generated: Mon Aug 12 09:35:47 2024
|